Taiwan Chest Disease Association Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01204307
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

cisplatin (platinol) (1 trial)

docetaxel (taxotere) (1 trial)

pemetrexed (alimta) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3